Gene: ZNF286A
Official Full Name: zinc finger protein 286Aprovided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in membrane. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12325 | ZNF286A Knockout cell line (HeLa) | Human | ZNF286A | 1:3~1:6 | Negative | Online Inquiry |
KO12326 | ZNF286A Knockout cell line (HCT 116) | Human | ZNF286A | 1:2~1:4 | Negative | Online Inquiry |
KO12327 | ZNF286A Knockout cell line (HEK293) | Human | ZNF286A | 1:3~1:6 | Negative | Online Inquiry |
KO12328 | ZNF286A Knockout cell line (A549) | Human | ZNF286A | 1:3~1:4 | Negative | Online Inquiry |
ZNF286A Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to lack the ZNF286A gene, a crucial element in the regulation of various cellular processes, including transcription and cellular growth regulation. These cell lines serve as invaluable tools for elucidating the role of ZNF286A in various biological contexts, allowing researchers to investigate how its absence affects cellular behavior, signaling pathways, and gene expression profiles.
The primary mechanism by which ZNF286A Gene Knockout Cell Lines operate involves the disruption of normal transcriptional processes, leading to modifications in cellular responses to external stimuli. The absence of this gene can induce changes in differentiation, apoptosis, and proliferation, thus providing a unique opportunity for scientists to explore the underlying mechanisms of diseases where ZNF286A plays a role, including certain cancers and developmental disorders.
From a scientific standpoint, these knockout cell lines are essential for research applications such as functional genomics, drug discovery, and disease modeling. By leveraging these models, researchers can gain insights into the pathogenic mechanisms associated with ZNF286A and identify potential therapeutic targets or biomarkers. Moreover, their use in high-throughput screening assays accelerates the identification of compounds that can modulate ZNF286A-related pathways.
Unlike traditional methods of gene silencing, such as RNA interference, the ZNF286A Gene Knockout Cell Lines provide a stable and heritable alteration in the genetic material, ensuring that experimental results are reproducible and reliable. This stability enhances the robustness of experimental outcomes, making these cell lines superior alternatives for long-term studies.
For researchers and clinicians aiming to deepen their understanding of ZNF286A's function and the broader implications in human health, these knockout cell lines represent a critical advancement in molecular biology tools. With the promise of novel insights into gene function and the potential for transformative discoveries, ZNF286A Gene Knockout Cell Lines stand as a hallmark product of our company's commitment to supporting innovative research endeavors. Our expertise in genetic engineering and cell line development further ensures the highest quality and reliability of these biological products, making us your trusted partner in advancing scientific knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.